BRIP1 GENE MUTATION
Clinical trials for BRIP1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new BRIP1 GENE MUTATION trials appear
Sign up with your email to follow new studies for BRIP1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope: targeted drug olaparib shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis study tests a drug called olaparib in people with metastatic breast cancer that has spread beyond the breast. Participants must have a specific genetic change in their tumor that may make it sensitive to this drug. The goal is to see if olaparib can shrink tumors or slow can…
Matched conditions: BRIP1 GENE MUTATION
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New drug combo targets prostate cancer in understudied groups
Disease control TerminatedThis study was designed to test a combination of two drugs, niraparib and abiraterone plus prednisone, in Hispanic/Latino and Black patients with a specific type of metastatic prostate cancer that has certain gene mutations. The goal was to see if the treatment could lower PSA le…
Matched conditions: BRIP1 GENE MUTATION
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Genetic counseling by phone may ease cancer worry in High-Risk women
Knowledge-focused TerminatedThis study looks at whether watching an online genetics video, with or without phone counseling, can reduce the stress women feel about their cancer risk. It involves 5,200 women aged 30 or older who have had triple-negative breast cancer and still have at least one ovary. Resear…
Matched conditions: BRIP1 GENE MUTATION
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:07 UTC
-
Can family testing prevent ovarian cancer? new study tracks who gets screened
Knowledge-focused OngoingThis study tracks how often family members of ovarian cancer patients with certain gene mutations (like BRCA) get tested themselves. The goal is to see if 'cascade testing' helps find more people at risk, so they can take steps to prevent cancer. About 118 patients and their rela…
Matched conditions: BRIP1 GENE MUTATION
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated May 26, 2026 05:01 UTC